Press Releases

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

June 20, 2025

C-Path’s T1D Consortium to Release a Clinical Trial Simulation Tool for New-Onset Trial Design

C-Path's Type 1 Diabetes Consortium today announced the release of a pilot version of their regulatory-grade new-onset clinical...

June 18, 2025

C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes

C-Path's Translational Therapeutics Accelerator (TRxA) proudly announced a $250,000 grant...

June 16, 2025

New Paper in Nature Reviews Drug Discovery Highlights How to Maximize the Regulatory Impact of Consortium-Based Projects

The paper, by authors from IHI and the Critical Path Institute, highlights the importance of a structured, strategic...

June 4, 2025

C-Path’s Translational Therapeutics Accelerator, Sontag Foundation Award Grant for Drug Development Project Targeting Pediatric Brain Tumors

C-Path today announced that its Translational Therapeutics Accelerator (TRxA) program...

May 29, 2025

Critical Path Institute and Citizen Health Partner to Accelerate Drug Development for Neuromuscular Disorders

C-Path, a global nonprofit accelerating drug development through data science and regulatory...

May 12, 2025

C-Path’s Translational Therapeutics Accelerator Awards $815,000 Grant for Drug Development Project in Advanced Prostate Cancer

C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today an $815,000 ($1,250,000 AUD) grant to Brian Dymock.

May 8, 2025

Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration

The year 2025 marks a historic milestone for C-Path as the organization celebrates...

May 6, 2025

C-Path Announces First Data Transfer from Takeda to Accelerate Alpha-1 Innovation

TUCSON, Ariz., May 6, 2025 — Critical Path Institute’s® (C-Path) Critical Path for Alpha-1 (CPA-1) consortium is proud to ann

April 23, 2025

C-Path Recognizes HIE Awareness Month, Calls for Global Collaboration to Accelerate Neonatal Drug Development

TUCSON, Ariz., April 22, 2025  — Critical Path Institute® (C-Path), through its International Neonatal Consortium (INC), jo

March 27, 2025

C-Path’s Predictive Safety Testing Consortium Advances a Transformative Test to Detect Drug Induced Liver Injury

Serum Glutamate Dehydrogenase Activity Enables Sensitive and Specific Diagnosis of Hepatocellular Injury in Humans TUCSON, Ariz.,

Previous34 5...31 Next